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ABSTRACT  
 
The aim of this study was to investigate the apolipoprotein-B (apo-B) gene in  atherosclerosis mice which were orally given curcuminoid 
extract of Curcuma xanthorriza. A total number of 30 white mice were split into 6 groups, the first group considered as control (without any 
treatment), second group as atherogenic feed control, the third group as extract control, while the fourth, fifth and sixth groups as atherogenic 
feed and curcuminoid Curcuma xanthorriza extract group treated with 5 mg/mouse, 10 mg/mouse and 15 mg/ mouse, respectively for three 
months. The blood samples were taken from all six groups for the deoxyribonucleic acid (DNA) analysis using total DNA isolation, DNA 
amplification with polymerase chain reaction (PCR), and DNA sequencing. The data analysis showed that 374 bp nucleotide sequence gen of 
apo-B from Rattus norvegicus in groups B, C, D, E, and F did not cause any changes in genes. The analysis showed the sequence of apo-B Rattus 
norvegicus gene in the treatment group was apparently identical with that of Rattus norvegicus group A as the control group without treatment.  
As conclusion, the administration of curcuminoid zanthorrizza to atherosclerosis mice did not change the gene structure of apo-B 100. 
____________________________________________________________________________________________________________________ 
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ABSTRAK 
 
Tujuan dari penelitian ini untuk mengkaji gambaran gen apolipoprotein-B (apo-B) pada tikus penderita arterosklerosis yang diberi ekstrak 
kurkuminoid. Sebanyak 30 ekor tikus putih dibagi menjadi 6 kelompok, kelompok pertama sebagai kontrol tanpa perlakuan apapun, kelompok 2 
sebagai kontrol pakan aterogenik, kelompok 3 kontrol ekstrak, dan 4, 5, dan 6 masing-masing diberi pakan aterogenik dan diberi kurkumonoid 
yang berbeda kosentrasinya (5 mg/ekor, 10 mg/ekor dan 15 mg/ekor) selama 3 bulan. Sampel darah diambil dari 6 kelompok untuk dianalisis 
deoxyribonucleic acid (DNA) yang terdiri dari isolasi total DNA, amplifikasi DNA dengan polymerase chain reaction (PCR), dan pengurutan 
DNA. Hasil penelitian menunjukkan bahwa gen apo-B pada urutan nukleotida 374 bp dari Rattus norvegicus kelompok B, C, D, E, dan F tidak 
menyebabkan perubahan pada gen tersebut. Hal ini didukung analisis yang menunjukkan bahawa sekuen gen apo-B Rattus norvegicus pada 
perlakuan identik dengan Rattus norvegicus kelompok A sebagai kontrol tanpa perlakuan. 
____________________________________________________________________________________________________________________ 
Kata kunci: pakan aterogenik, ekstrak temulawak gen apo-B, pengurutan 
 
 
INTRODUCTION 
 
Fatty acids enter the blood vessels in the body in the 
form of lipoprotein particles, especially, low-density 
lipoprotein (LDL). Apolipoprotein-B (apo-B) 100 plays 
an important role in atherosclerosis. The interaction 
between apo-B 100 and the artery walls causes the 
LDL particles to be retained inside the interior of artery 
walls. These retained apo-B lipoprotein particles 
increase the risk of atherosclerosis when the lipoprotein 
particles are converted into harmful particles that 
increase the risk of coronary heart disease (CHD). 
Currently, herbal medicines have been massively 
developed from the herb plants that easily grow in 
Indonesia. Indonesia is rich with its biodiversity worth 
exploiting. Turmeric (Curcuma longa) has been grown 
as an ingredient of traditional medicine for centuries. 
Its drug potency is due to its proven anti-inflammatory 
and anti-germ substances (Tonnesen et al., 1987) and 
anti-rheumatism benefits (Kiso et al., 1983). Even 
turmeric is believed to have anti-tumor and antioxidant 
potency with its active substances called curcuminoid 
and flavonoids. Based on this condition, the researchers 
intended to study how much the effect of curcuminoid 
extract of Javanese turmeric can inhibit (suppress) the 
formation of atherosclerosis plaque in mice fed with 
atherogenic feed. 
Javanese turmeric (Curcuma xanthorrhiza Roxb) is 
now massively grown as medicinal plants. Curcumin is 
the active substance contained in this plant type of 
Zingiberacea. Chemically, curcuminoids are 
diferuloylmethane derivatives comprising demethoxy 
diferuloylmethane (curcumin) and monodesmethoxy 
diferuloylmethane (desmethoxy-curcumin). Curcumin 
has a molecular formula of C21H20O6 with a molecular 
weight of 368 bp. Currcumin is yellow and easily turns 
brownish because of sunlight (Quiles et al., 2002; 
Sreejayan and Rao, 1997). Curcumin is stable below 
pH 6.5 and will change its structure when it is above 
pH 6.5. Other types of curcumin are bisdesmethoxy-
curcumin and desmethoxy-curcumin. 
Based on the curcuminoid structure, the methoxy 
group presented in bis-desmetoxy-curcumin is replaced 
by a hydrogen atom. The phenolic group is thought to 
function as antibacterial. Accordingly, the curcumin 
has the ability to eliminate the oxygen radical 
derivatives presented in the media and is responsible 
for lipid peroxidation in the cells. This phenolic group 
is essential for superoxide scavenger and the presence 
of ortho methoxy group in the phenolic molecules will 
increase the activity of curcumin (Rao 1995; Sreejayan 
and Rao, 1997). 
The oxidized LDL molecules stimulate the 
scavenger receptors from the macrophages to capture 
the LDL continuously to form the foam cells. 
According to the theory found by Steinberg (1993), 
atherosclerotic lesions are initiated by the oxidation of 
LDL resulting in endothelial expression of monocyte 
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attachment and resulting in monocyte chemotactic 
protein (MCP), macrophage colony stimulating factor 
(M-CSF). Such induction causes monocytes to turn into 
macrophages and attach to the endothelium. 
Furthermore, the macrophages phagocytosis the 
oxidized LDL which accumulates in the blood vessel 
walls, forming foam cells and finally forming an early 
lesion known as fatty streak. The oxidized LDL also 
stimulates growth factors such as platelet ground factor 
derivate (PGDF) resulting in the proliferation and 
migration of smooth muscle cells of the blood vessels. 
The oxidized LDL also stimulates the formation of free 
radicals, thus aggravating the process of 
atherosclerosis. 
High cholesterol in blood, such as total serum 
cholesterol, triglycerides, low-density lipoprotein 
cholesterol (LDL-C), apolipoprotein (apo-B), or low 
levels of high-density lipoprotein (HDL-C) and apo-
A1, is a sign of the risk factors for coronary heart 
diseases. There are two main forms of apo-B, namely, 
apo-B 48 and apo-B 100. Apo-B 48 is synthesized 
mainly by the small intestine. Apo-B 100 is an 
apolipoprotein found in lipoproteins synthesized by the 
liver (Law et al., 1985). Therefore, based on the 
viewpoint of atherosclerosis and cardiovascular risks, 
apo-B 100 is important. Apo-B 48 molecules are 
usually found in the same forms as apo-B 100, very-
low-density lipoprotein (VLDL), intermediate-density 
lipoprotein (IDL), LDL and lipoprotein-A particles and 
all of these particles are atherogenic. Each of these 
particles contains a single apo-B molecule. Therefore, 
the analysis of apo-B genes, which are the major 
lipoprotein particles involved directly in the 
atherosclerosis process, is highly beneficial. Typically, 
85-90% apo-B is presented in LDL particles. Thus, 
apo-B reflects the particle concentrations similar to 
LDL (Tabas et al., 2007; McQueen et al., 2008). 
Atherosclerosis is a degenerative disorder of large 
and medium vessels characterized by thickening of 
blood vessels (Munro and Cotrans, 1988). The 
thickening of blood vessels is due to the lipid 
accumulation and fibrous elements in the medium and 
large arteries. Ultimately, the obstruction occurs in the 
lumen of the artery. Atherosclerosis generally attacks 
the coronary arteries, aorta, iliac, femoral, and cerebral 
arteries (Ross and Glomset, 1976). The thickening of 
these blood vessels is characterized by the presence of 
foam cells, namely, macrophage cells that contain 
cholesterol and ester cholesterol. The formation of 
foam cells is caused by the excessive macrophages 
taking oxidized LDL. In addition to cholesterol or ester 
cholesterol, in atherosclerotic lesions, there are also 
proteins, carbohydrates, and cellular components 
including smooth muscle cells, macrophages, and 
lymphocytes (Kaplan and Aviram, 2001). 
According to Hansson (2009), atherosclerosis is an 
inflammatory disease. The process of atherosclerosis 
begins when LDL accumulates in the intima, activating 
the endothelium, increasing the retrieval of monocytes 
and T cells. Monocytes undergo the differentiation 
stages to form macrophages, converting lipoproteins 
into foam cells. Meanwhile, T cells in the lesions will 
recognize local antigens that contribute to plaque 
formation. The initial change in the process of 
atherosclerosis involves the inside of the blood vessels. 
The atherosclerosis begins since the childhood 
characterized by the development of fatty streak in the 
blood vessels (Rackley, 2007). The continuous fatty 
streaks form fatty plaques that can be examined 
biochemically and microscopically (Small, 1988; Stary 
et al., 1990). Fatty streaks can be found in human 
arteries since their teens. An autopsy study of 2,876 
men and women aged 15-34 years showed the fatty 
streaks in the aorta (Rackley, 2007). Fatty streaks are 
precursors to atherosclerotic plaques of further stages. 
It turns out that genetic factors are a major factor 
affecting the acceleration of fatty streaks into 
atherosclerotic plaques (McGill, 1968). This study was 
aimed at assessing the mechanism of the Javanese 
turmeric’s curcumonoid in the early process of 
atherosclerosis by analyzing the gene DNA encoding 
apo-B, the causal factor of atherosclerosis at the 
cellular level in vivo, and to determine the appropriate 
dose of Javanese turmeric extract. 
 
MATERIALS AND METHODS 
 
A total of 30 white rats were divided into 6 groups, 
group 1 functioned as the control group without any 
treatment, group 2 as control group with atherogenic 
feed, group 3 as control group with turmeric extract, 
and groups 4, 5 and 6 as the treatment groups, which 
were fed with atherogenic feed and given curcumonoid 
with different concentrations (5 mg/each rat, 10 
mg/each rat and 20 mg/each rat, respectively) for 3 
months. 
 
Total DNA Isolation 
The total DNA was obtained from the extraction of 
blood. The blood was taken from blood vessels and 
added with 10% ethylenediaminetetraacetic acid 
(EDTA) solution as anticoagulant. The preparation of 
blood samples followed Duryadi method (1993). As 
many as 50-100 μL blood was added with 1x lysis 
solution. The blood was then supplemented with 
digestion buffer (500 mg of STES + 0.5 mg/mL 
Proteinase K) solution. Then it was incubated at the 
water with temperature of 55 C for 16 hours or 
overnight. The total DNA purification followed the 
procedure in DNA isolation kit. 
 
DNA Fragment Amplification with PCR 
The polymerase chain reaction (PCR) amplication 
for the apo-B region was carried out under the 
following conditions: The initial pre-denaturation for 5 
minutes at 94 C followed by a denaturation 
temperature of 94 C for 30 seconds, annealing at     
53 C for 45 seconds, elongation at 72 C for 1 minute; 
for 35 cycles, then ended with the 5 minute extension 
reaction at 72 C using apo-B primer (Forwards 
5'AATGTCTGACTGTGGGGACAC3'; Reverse 5'GC 
CCAAATCCTTTCCTCC TAGA3') 
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Gel Agarose Electrophoresis 
The PCR product was transferred to 2% agarose gel 
using a 1x TBE buffer in Submirine Electrophoresis 
(Hoefer, USA). Band observations were carried out 
with the help of UV rays (λ = 300 nm). A DNA marker 
of 100 bp was used as a molecular weight marker. 
 
DNA Sequencing 
The amplified PCR product was purified by using 
the GFX Column Purification Kit (Amersham, USA), 
The result was used as a DNA template for DNA 
sequencing reaction. The conditions for the sequencing 
reaction were as follows: the initial denaturation lasted 
for 2 minutes at 94 C followed by denaturation at    
55 C for 45 seconds, and at 72 C for 1 minute (35 
cycles), then terminated with a 5 minute extension at 
72 C. The sequencing reaction product was purified 
using Column outoseq G-50, then the DNA was 
concentrated with the addition of absolute alcohol 
followed by 70% alcohol washing. When the 
concentrated DNA was drying, the 6 μL stop solution 
was added. The solution was incubated at 72° C for 5 
minutes and was inserted into the ice. For DNA 
sequencing, ALFexpres II DNA sequencing automatic 
device (Amersam Pharmacia, Biotech) was used at 
1500 V, 60 mA electric current, 25 W power, and     
55 C for 700 minutes. 
The reaction for the determination of apo-B gene 
was done by using the solution reactor Thermo 
Sequentase Cy5 Dye Terminator Cycle Sequencer Kit 
(Amersam, USA) with GeneAmpRPCR System 
machine (Perkin Elmer). The conditions for the trace 
determination reaction were as follows: The product of 
the determination reaction of trace was purified by 
using Column outoseq G-50, and then the DNA was 
concentrated with the addition of absolute alcohol 
followed by 70% alcohol washing. After the DNA was 
dried, 6 μL stop solution was added to it. The solution 
was incubated at 72 C for 5 minutes. Then the solution 
was inserted into the ice. The nucleotide was traced by 
using a DNA tracer ALFexpres II (Amersam 
Pharmacia, Biotech) at 1500 V, electric current 60 mA, 
25 W power, 55 C for 700 min. 
The total DNA was isolated from 6 samples of 
white rat (Rattus norvegicus) with codes A1 and A2 for 
rats with normal feeding, B1 and B2 for rats with 
normal feeding plus 5% extract, C1 and C2 for rats 
treated with 10% cholesterol without extract, D1 and 
D2 for rats treated with 10% cholesterol feed plus 5% 
extract, E1 and E2 for rats treated 10% cholesterol feed 
plus 10% extract, F1 and F2 for rats treated with 10% 
cholesterol feeding plus 20% extract. 
 
RESULTS AND DISCUSSION 
 
Apo-B Amplification of Genes by PCR Technique 
Amplification of apo-B Rattus norvegicus genes 
with primary apo-B F and apo-B R produced a 497 bp 
PCR product. The sequence of apo-B genes in 
chromosome number 6 was located between the spacer 
base (on the left or front) and the spacer (to the right or 
the back) (Gibbs et al., 2013). The electrophoresis of 
apo-B gene amplification results was shown in Figure 
1, 2, and 3. 
The amplification results of primary apo-B F and 
apo-B R based on chromosome genome sequence 
number 6 (Gibbs et al., 2013) consisted of 497 bp of 
partial apo-B gene. The result of this amplification was 
located in the apo-B gene from the sequence of 27.323 
bp to that of 27.696 bp. The target gene was an exon of 
374 bp apo-B. The schemes of the apo-B gene and the 
amplification product are shown in Figure 4. 
The primary apo-B F and apo-B R had 21 and 22 
nucleotides. The primary attachment of apo-B F and 
apo-B R was located at apo-B genes. The primary 
attachment schemes and amplification area are shown 
in Figure 5. 
 
Determination of Nucleotide Sequences with MEGA 
Program 6.06 
The DNA sequence analysis of Rattus norvegicus 
was done by multiple alignments with DNA sequences 
of the apo-B Rattus norvegicus genes from Genbank. 
The nucleotide of apo-B Rattus norvegicus gene from 
Genbank was used as a long nucleotide standard to be 
analyzed. The fragment of sequenced DNA with apo-B  
 
Figure 1. Electrophoresis of DNA isolation of total Rattus norvegicus using gel agarose 1%. A1= Rattus norvegicus A1; A2= Rattus 
norvegicus A2; B1= Rattus norvegicus B1; B2= Rattus norvegicus B2; C1= Rattus norvegicus C1; C2= Rattus norvegicus C2; D1= Rattus 
norvegicus D1; D= Rattus norvegicus D2; E1= Rattus norvegicus E1; E2 = Rattus norvegicus E2; F1= Rattus norvegicus F1; F2= Rattus 
norvegicus F2; DNA ladder 100 bp (Genaid) 
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Figure 2. Electrophorosis of apo-B gene amplification of sample  Rattus norvegicus using gel agarose 2%. A1= Rattus norvegicus 
A1; B1= Rattus norvegicus B1; C1= Rattus norvegicus C1; D1= Rattus norvegicus D1; E1= Rattus norvegicus E1; F1= Rattus norvegicus F1; 
D2= Rattus norvegicus D2; D3= Rattus norvegicus D3; D5= Rattus norvegicus D5; DNA ladder 100 bp (Genaid) 
 
 
Figure 3. Electrophorosis of apo-B gen amplification of sample R. norvegicus using gel agarosa 1.2 %. A1= Rattus norvegicus A1; 
B1= Rattus norvegicus B1; C1= Rattus norvegicus C1; D1= Rattus norvegicus D1; E1= Rattus norvegicus E1; F1= Rattus norvegicus F1; D2= 
Rattus norvegicus D2; D3= Rattus norvegicus D3; D5= Rattus norvegicus D5; DNA ladder 100 bp (Genaid) 
 
 
 
Figure 4. Schematic layout of apo-B genes and partial apo-B gene amplification products 
 
 
Figure 5. Schematic of forward and reverse primary attachment in apo-B Genes of Rattus norvegicus 
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F and apo-B R primers along 497 bp produced 374-nt 
apo-B encoding genes. The alignment based on Rattus 
norvegicus (Genbank) DNA fragment produced the 
segment as along as 374 bp. The alignment results 
between 374 bp apo-B genes in this research and Rattus 
norvegicus Genbank as a comparison produced an 
identical nucleotide. The nucleotide differences in the 
Rattus norvegicus of the study are shown in Table 1. 
The multiple alignment results between Rattus 
norvegicus samples, and Rattus norvegicus (Genbank) 
were found 0. The number 0 indicated that there was no 
nucleotide difference from the compared samples. The 
apo-B gene sequences of Rattus norvegicus samples 
compared were identical. There were no differences in 
rats A1 and A2 as controls compared with the treated 
B1, B2, C1, C2, D1, D2, E1, E2, F1, and F2 rats. The 
different treatments did not cause any changes to the 
apo-B gene. 
The results of this study showed that the 
administration of curcuminoid extracts of 5%, 10%, 
and 20% to the rats fed with10% atherogenic feeding 
did not change the structure of the apo-B 100 gene 
associated with cholesterol. This result means the 
administration of 5-20% curcuminoid extracts neither 
prevented nor reduced atherosclerosis. Some other 
researches showed contradictory findings with the 
results of the present study. Tian et al. (2014) reported 
that the application of curcumin on rats reduced the 
level of apo-B 100 which could prevent the 
atherosclerosis in long run. Hussein et al. (2018) 
reported similarly that the administration of curcumin 
to the atherosclerosis rats reduced the apo-B 
concentration. 
From the present study the authors noted that the 
different results of the study could be caused by the 
small amount of curcuminoid extract (5-20 mg/a 
mouse) administered to the rats compared to the 200 
mg/kg, body weight as reported by Hussein et al. 
(2018).  
 
CONCLUSION 
 
Based on 374 bp of the apo-B gene nucleotide 
sequence from Rattus norvegicus groups of B, C, D, E, 
and F analyzed using MEGA program version 6.06, 
curcuminoid extract of Javanese turmeric (Curcuma 
xanthorrhiza Roxb given in the diet as a treatment did 
not cause changes in the apo B-100 gene. The present 
study showed that the apo-B gene sequence of Rattus 
norvegicus from the treatment groups was identical to 
that of Rattus norvegicus group A as the control 
without treatment. 
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